A multicentre, randomized, naturalistic, open-label study between aripripazole and standard of care in the management of community-treated schizophrenic patients. Schizophrenia Trial of Aripripazole: (STAR) study - Kerwin, R; Millet, B; Herman, E (Eur Psychiatry, 2007)
et al.